 | • レポートコード：MRC2Q12-16839 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、組換えタンパク質試薬のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 組換えタンパク質試薬のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 組換えタンパク質試薬の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 組換えタンパク質試薬のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの組換えタンパク質試薬の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の組換えタンパク質試薬の売上および2028年までの予測に焦点を当てています。 組換えタンパク質試薬のグローバル主要企業には、Abcam PLC、R&D Systems、Miltenyi Biotec、Merck KGaA、ThermoFisher Scientific、GE Healthcare、Lonza、Eurogentec (Kaneka Corporation)、PeproTech、BPS Bioscience、Reprocell、Abnova Corporation、GenScript Biotech Corporation、ProSpec Tany TechnoGene、Novoprotein、Sino Biological、ACROBiosystems Groupなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 組換えタンパク質試薬市場は、タイプとアプリケーションによって区分されます。世界の組換えタンパク質試薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 ホルモン、成長因子、サイトカイン、血漿タンパク質因子、組換え代謝酵素、免疫チェックポイント制御因子、その他 【アプリケーション別セグメント】 バイオ医薬品企業、学術/研究機関、受託研究機関 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 組換えタンパク質試薬製品概要 - タイプ別市場（ホルモン、成長因子、サイトカイン、血漿タンパク質因子、組換え代謝酵素、免疫チェックポイント制御因子、その他） - アプリケーション別市場（バイオ医薬品企業、学術/研究機関、受託研究機関） - 調査の目的 ・エグゼクティブサマリー - 世界の組換えタンパク質試薬販売量予測2017-2028 - 世界の組換えタンパク質試薬売上予測2017-2028 - 組換えタンパク質試薬の地域別販売量 - 組換えタンパク質試薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別組換えタンパク質試薬販売量 - 主要メーカー別組換えタンパク質試薬売上 - 主要メーカー別組換えタンパク質試薬価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（ホルモン、成長因子、サイトカイン、血漿タンパク質因子、組換え代謝酵素、免疫チェックポイント制御因子、その他） - 組換えタンパク質試薬のタイプ別販売量 - 組換えタンパク質試薬のタイプ別売上 - 組換えタンパク質試薬のタイプ別価格 ・アプリケーション別市場規模（バイオ医薬品企業、学術/研究機関、受託研究機関） - 組換えタンパク質試薬のアプリケーション別販売量 - 組換えタンパク質試薬のアプリケーション別売上 - 組換えタンパク質試薬のアプリケーション別価格 ・北米市場 - 北米の組換えタンパク質試薬市場規模（タイプ別、アプリケーション別） - 主要国別の組換えタンパク質試薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの組換えタンパク質試薬市場規模（タイプ別、アプリケーション別） - 主要国別の組換えタンパク質試薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の組換えタンパク質試薬市場規模（タイプ別、アプリケーション別） - 主要国別の組換えタンパク質試薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の組換えタンパク質試薬市場規模（タイプ別、アプリケーション別） - 主要国別の組換えタンパク質試薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの組換えタンパク質試薬市場規模（タイプ別、アプリケーション別） - 主要国別の組換えタンパク質試薬市場規模（トルコ、サウジアラビア） ・企業情報 Abcam PLC、R&D Systems、Miltenyi Biotec、Merck KGaA、ThermoFisher Scientific、GE Healthcare、Lonza、Eurogentec (Kaneka Corporation)、PeproTech、BPS Bioscience、Reprocell、Abnova Corporation、GenScript Biotech Corporation、ProSpec Tany TechnoGene、Novoprotein、Sino Biological、ACROBiosystems Group ・産業チェーン及び販売チャネル分析 - 組換えタンパク質試薬の産業チェーン分析 - 組換えタンパク質試薬の原材料 - 組換えタンパク質試薬の生産プロセス - 組換えタンパク質試薬の販売及びマーケティング - 組換えタンパク質試薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 組換えタンパク質試薬の産業動向 - 組換えタンパク質試薬のマーケットドライバー - 組換えタンパク質試薬の課題 - 組換えタンパク質試薬の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Recombinant Protein Reagents estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Recombinant Protein Reagents is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Recombinant Protein Reagents is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Recombinant Protein Reagents is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Recombinant Protein Reagents include Abcam PLC, R&D Systems, Miltenyi Biotec, Merck KGaA, ThermoFisher Scientific, GE Healthcare, Lonza, Eurogentec (Kaneka Corporation) and PeproTech, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Recombinant Protein Reagents companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Recombinant Protein Reagents market. Further, it explains the major drivers and regional dynamics of the global Recombinant Protein Reagents market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Abcam PLC
R&D Systems
Miltenyi Biotec
Merck KGaA
ThermoFisher Scientific
GE Healthcare
Lonza
Eurogentec (Kaneka Corporation)
PeproTech
BPS Bioscience
Reprocell
Abnova Corporation
GenScript Biotech Corporation
ProSpec Tany TechnoGene
Novoprotein
Sino Biological
ACROBiosystems Group
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Recombinant Protein Reagents Segment by Type
Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
Recombinant Protein Reagents Segment by Application
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Recombinant Protein Reagents market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Recombinant Protein Reagents market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Recombinant Protein Reagents, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Recombinant Protein Reagents, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Recombinant Protein Reagents revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Recombinant Protein Reagents market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Recombinant Protein Reagents revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abcam PLC, R&D Systems, Miltenyi Biotec, Merck KGaA, ThermoFisher Scientific, GE Healthcare, Lonza, Eurogentec (Kaneka Corporation) and PeproTech, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Recombinant Protein Reagents in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant Protein Reagents companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Protein Reagents revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Protein Reagents Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Hormones
1.2.3 Growth Factors
1.2.4 Cytokines
1.2.5 Plasma Protein Factor
1.2.6 Recombinant Metabolic Enzymes
1.2.7 Immune Checkpoint Regulators
1.2.8 Others
1.3 Market by Application
1.3.1 Global Recombinant Protein Reagents Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Biopharmaceutical Companies
1.3.3 Academic and Research Institutes
1.3.4 Contract Research Organizations
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Protein Reagents Market Perspective (2017-2028)
2.2 Recombinant Protein Reagents Growth Trends by Region
2.2.1 Recombinant Protein Reagents Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Recombinant Protein Reagents Historic Market Size by Region (2017-2022)
2.2.3 Recombinant Protein Reagents Forecasted Market Size by Region (2023-2028)
2.3 Recombinant Protein Reagents Market Dynamics
2.3.1 Recombinant Protein Reagents Industry Trends
2.3.2 Recombinant Protein Reagents Market Drivers
2.3.3 Recombinant Protein Reagents Market Challenges
2.3.4 Recombinant Protein Reagents Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Protein Reagents Players by Revenue
3.1.1 Global Top Recombinant Protein Reagents Players by Revenue (2017-2022)
3.1.2 Global Recombinant Protein Reagents Revenue Market Share by Players (2017-2022)
3.2 Global Recombinant Protein Reagents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Recombinant Protein Reagents Revenue
3.4 Global Recombinant Protein Reagents Market Concentration Ratio
3.4.1 Global Recombinant Protein Reagents Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Protein Reagents Revenue in 2021
3.5 Recombinant Protein Reagents Key Players Head office and Area Served
3.6 Key Players Recombinant Protein Reagents Product Solution and Service
3.7 Date of Enter into Recombinant Protein Reagents Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Protein Reagents Breakdown Data by Type
4.1 Global Recombinant Protein Reagents Historic Market Size by Type (2017-2022)
4.2 Global Recombinant Protein Reagents Forecasted Market Size by Type (2023-2028)
5 Recombinant Protein Reagents Breakdown Data by Application
5.1 Global Recombinant Protein Reagents Historic Market Size by Application (2017-2022)
5.2 Global Recombinant Protein Reagents Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Recombinant Protein Reagents Market Size (2017-2028)
6.2 North America Recombinant Protein Reagents Market Size by Type
6.2.1 North America Recombinant Protein Reagents Market Size by Type (2017-2022)
6.2.2 North America Recombinant Protein Reagents Market Size by Type (2023-2028)
6.2.3 North America Recombinant Protein Reagents Market Share by Type (2017-2028)
6.3 North America Recombinant Protein Reagents Market Size by Application
6.3.1 North America Recombinant Protein Reagents Market Size by Application (2017-2022)
6.3.2 North America Recombinant Protein Reagents Market Size by Application (2023-2028)
6.3.3 North America Recombinant Protein Reagents Market Share by Application (2017-2028)
6.4 North America Recombinant Protein Reagents Market Size by Country
6.4.1 North America Recombinant Protein Reagents Market Size by Country (2017-2022)
6.4.2 North America Recombinant Protein Reagents Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Recombinant Protein Reagents Market Size (2017-2028)
7.2 Europe Recombinant Protein Reagents Market Size by Type
7.2.1 Europe Recombinant Protein Reagents Market Size by Type (2017-2022)
7.2.2 Europe Recombinant Protein Reagents Market Size by Type (2023-2028)
7.2.3 Europe Recombinant Protein Reagents Market Share by Type (2017-2028)
7.3 Europe Recombinant Protein Reagents Market Size by Application
7.3.1 Europe Recombinant Protein Reagents Market Size by Application (2017-2022)
7.3.2 Europe Recombinant Protein Reagents Market Size by Application (2023-2028)
7.3.3 Europe Recombinant Protein Reagents Market Share by Application (2017-2028)
7.4 Europe Recombinant Protein Reagents Market Size by Country
7.4.1 Europe Recombinant Protein Reagents Market Size by Country (2017-2022)
7.4.2 Europe Recombinant Protein Reagents Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Protein Reagents Market Size (2017-2028)
8.2 Asia-Pacific Recombinant Protein Reagents Market Size by Type
8.2.1 Asia-Pacific Recombinant Protein Reagents Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Recombinant Protein Reagents Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Recombinant Protein Reagents Market Share by Type (2017-2028)
8.3 Asia-Pacific Recombinant Protein Reagents Market Size by Application
8.3.1 Asia-Pacific Recombinant Protein Reagents Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Recombinant Protein Reagents Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Recombinant Protein Reagents Market Share by Application (2017-2028)
8.4 Asia-Pacific Recombinant Protein Reagents Market Size by Region
8.4.1 Asia-Pacific Recombinant Protein Reagents Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Recombinant Protein Reagents Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Recombinant Protein Reagents Market Size (2017-2028)
9.2 Latin America Recombinant Protein Reagents Market Size by Type
9.2.1 Latin America Recombinant Protein Reagents Market Size by Type (2017-2022)
9.2.2 Latin America Recombinant Protein Reagents Market Size by Type (2023-2028)
9.2.3 Latin America Recombinant Protein Reagents Market Share by Type (2017-2028)
9.3 Latin America Recombinant Protein Reagents Market Size by Application
9.3.1 Latin America Recombinant Protein Reagents Market Size by Application (2017-2022)
9.3.2 Latin America Recombinant Protein Reagents Market Size by Application (2023-2028)
9.3.3 Latin America Recombinant Protein Reagents Market Share by Application (2017-2028)
9.4 Latin America Recombinant Protein Reagents Market Size by Country
9.4.1 Latin America Recombinant Protein Reagents Market Size by Country (2017-2022)
9.4.2 Latin America Recombinant Protein Reagents Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant Protein Reagents Market Size (2017-2028)
10.2 Middle East & Africa Recombinant Protein Reagents Market Size by Type
10.2.1 Middle East & Africa Recombinant Protein Reagents Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Recombinant Protein Reagents Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Recombinant Protein Reagents Market Share by Type (2017-2028)
10.3 Middle East & Africa Recombinant Protein Reagents Market Size by Application
10.3.1 Middle East & Africa Recombinant Protein Reagents Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Recombinant Protein Reagents Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Recombinant Protein Reagents Market Share by Application (2017-2028)
10.4 Middle East & Africa Recombinant Protein Reagents Market Size by Country
10.4.1 Middle East & Africa Recombinant Protein Reagents Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Recombinant Protein Reagents Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abcam PLC
11.1.1 Abcam PLC Company Details
11.1.2 Abcam PLC Business Overview
11.1.3 Abcam PLC Recombinant Protein Reagents Introduction
11.1.4 Abcam PLC Revenue in Recombinant Protein Reagents Business (2017-2022)
11.1.5 Abcam PLC Recent Developments
11.2 R&D Systems
11.2.1 R&D Systems Company Details
11.2.2 R&D Systems Business Overview
11.2.3 R&D Systems Recombinant Protein Reagents Introduction
11.2.4 R&D Systems Revenue in Recombinant Protein Reagents Business (2017-2022)
11.2.5 R&D Systems Recent Developments
11.3 Miltenyi Biotec
11.3.1 Miltenyi Biotec Company Details
11.3.2 Miltenyi Biotec Business Overview
11.3.3 Miltenyi Biotec Recombinant Protein Reagents Introduction
11.3.4 Miltenyi Biotec Revenue in Recombinant Protein Reagents Business (2017-2022)
11.3.5 Miltenyi Biotec Recent Developments
11.4 Merck KGaA
11.4.1 Merck KGaA Company Details
11.4.2 Merck KGaA Business Overview
11.4.3 Merck KGaA Recombinant Protein Reagents Introduction
11.4.4 Merck KGaA Revenue in Recombinant Protein Reagents Business (2017-2022)
11.4.5 Merck KGaA Recent Developments
11.5 ThermoFisher Scientific
11.5.1 ThermoFisher Scientific Company Details
11.5.2 ThermoFisher Scientific Business Overview
11.5.3 ThermoFisher Scientific Recombinant Protein Reagents Introduction
11.5.4 ThermoFisher Scientific Revenue in Recombinant Protein Reagents Business (2017-2022)
11.5.5 ThermoFisher Scientific Recent Developments
11.6 GE Healthcare
11.6.1 GE Healthcare Company Details
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare Recombinant Protein Reagents Introduction
11.6.4 GE Healthcare Revenue in Recombinant Protein Reagents Business (2017-2022)
11.6.5 GE Healthcare Recent Developments
11.7 Lonza
11.7.1 Lonza Company Details
11.7.2 Lonza Business Overview
11.7.3 Lonza Recombinant Protein Reagents Introduction
11.7.4 Lonza Revenue in Recombinant Protein Reagents Business (2017-2022)
11.7.5 Lonza Recent Developments
11.8 Eurogentec (Kaneka Corporation)
11.8.1 Eurogentec (Kaneka Corporation) Company Details
11.8.2 Eurogentec (Kaneka Corporation) Business Overview
11.8.3 Eurogentec (Kaneka Corporation) Recombinant Protein Reagents Introduction
11.8.4 Eurogentec (Kaneka Corporation) Revenue in Recombinant Protein Reagents Business (2017-2022)
11.8.5 Eurogentec (Kaneka Corporation) Recent Developments
11.9 PeproTech
11.9.1 PeproTech Company Details
11.9.2 PeproTech Business Overview
11.9.3 PeproTech Recombinant Protein Reagents Introduction
11.9.4 PeproTech Revenue in Recombinant Protein Reagents Business (2017-2022)
11.9.5 PeproTech Recent Developments
11.10 BPS Bioscience
11.10.1 BPS Bioscience Company Details
11.10.2 BPS Bioscience Business Overview
11.10.3 BPS Bioscience Recombinant Protein Reagents Introduction
11.10.4 BPS Bioscience Revenue in Recombinant Protein Reagents Business (2017-2022)
11.10.5 BPS Bioscience Recent Developments
11.11 Reprocell
11.11.1 Reprocell Company Details
11.11.2 Reprocell Business Overview
11.11.3 Reprocell Recombinant Protein Reagents Introduction
11.11.4 Reprocell Revenue in Recombinant Protein Reagents Business (2017-2022)
11.11.5 Reprocell Recent Developments
11.12 Abnova Corporation
11.12.1 Abnova Corporation Company Details
11.12.2 Abnova Corporation Business Overview
11.12.3 Abnova Corporation Recombinant Protein Reagents Introduction
11.12.4 Abnova Corporation Revenue in Recombinant Protein Reagents Business (2017-2022)
11.12.5 Abnova Corporation Recent Developments
11.13 GenScript Biotech Corporation
11.13.1 GenScript Biotech Corporation Company Details
11.13.2 GenScript Biotech Corporation Business Overview
11.13.3 GenScript Biotech Corporation Recombinant Protein Reagents Introduction
11.13.4 GenScript Biotech Corporation Revenue in Recombinant Protein Reagents Business (2017-2022)
11.13.5 GenScript Biotech Corporation Recent Developments
11.14 ProSpec Tany TechnoGene
11.14.1 ProSpec Tany TechnoGene Company Details
11.14.2 ProSpec Tany TechnoGene Business Overview
11.14.3 ProSpec Tany TechnoGene Recombinant Protein Reagents Introduction
11.14.4 ProSpec Tany TechnoGene Revenue in Recombinant Protein Reagents Business (2017-2022)
11.14.5 ProSpec Tany TechnoGene Recent Developments
11.15 Novoprotein
11.15.1 Novoprotein Company Details
11.15.2 Novoprotein Business Overview
11.15.3 Novoprotein Recombinant Protein Reagents Introduction
11.15.4 Novoprotein Revenue in Recombinant Protein Reagents Business (2017-2022)
11.15.5 Novoprotein Recent Developments
11.16 Sino Biological
11.16.1 Sino Biological Company Details
11.16.2 Sino Biological Business Overview
11.16.3 Sino Biological Recombinant Protein Reagents Introduction
11.16.4 Sino Biological Revenue in Recombinant Protein Reagents Business (2017-2022)
11.16.5 Sino Biological Recent Developments
11.17 ACROBiosystems Group
11.17.1 ACROBiosystems Group Company Details
11.17.2 ACROBiosystems Group Business Overview
11.17.3 ACROBiosystems Group Recombinant Protein Reagents Introduction
11.17.4 ACROBiosystems Group Revenue in Recombinant Protein Reagents Business (2017-2022)
11.17.5 ACROBiosystems Group Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer